Company Information

KRSNAA DIAGNOSTICS LTD.

NSE : KRSNAABSE : 543328ISIN CODE : INE08LI01020Industry : Hospital & Healthcare ServicesHouse : Private
BSE586.903.5 (+0.6 %)
PREV CLOSE ( ) 583.40
OPEN PRICE ( ) 582.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1837
TODAY'S LOW / HIGH ( )574.00 591.10
52 WK LOW / HIGH ( )448.7 788.6
NSE589.004.75 (+0.81 %)
PREV CLOSE( ) 584.25
OPEN PRICE ( ) 580.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 589.00 (19)
VOLUME 26359
TODAY'S LOW / HIGH( ) 573.35 592.35
52 WK LOW / HIGH ( )448.6 767.9
ChairmanRajendra Mutha
Company SecretarySujoy Sudipta Bose
Executive DirectorPallavi Bhatevara
Nominee DirectorPrem Pradeep
Joint Managing DirectorYash Mutha
Non Executive Independent DirectorChetan Desai
Chhaya Palrecha
Rajiva Ranjan Verma
Adesh Kumar Gupta
Incorporation Year : 22-12 2010

Registered Office :

Address : S. No. 243, A- Hissa No. 6,Cts No. 4519, 4519/1, Near Chinchwad Station,Chinchwad, Taluka – Haveli Pune,
Maharashtra-411019 .

Phone : 020-29780210 / 11 / 12

Industry : Hospital & Healthcare Services

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.